About
Dr. Hao received his Ph.D. at Xiamen University in China, and engaged in research on tumor cell signal transduction. After obtaining his doctoral degree, Dr. Hao moved to the United States to pursue his postdoc training at Albany Medical Center and New York University School of Medicine, working on non-coding RNA and kidney stem cell study, respectively. Dr. Hao came to Charles R. Drew University of Medicine and Science (CDU) to continue his beloved research on the etiology of tumors and became an assistant professor at CDU, mainly engaged in metabolism-related cancer research. Meanwhile, he was also discovering new small-molecule drugs for cancer treatment.
Research Interests
Dr. Hao has a broad background in biomedicine, particularly with expertise in molecular genetics and cancer cell biology.
Specifically, Dr. Hao’s research primarily focuses on the following areas: (1) In-depth investigation of non-coding RNAs (microRNA, long non-coding RNA, and circRNA) and their role in epigenetic regulation of cancer, particularly metabolic abnormalities-associated cancer, (2) unveiling the function of RNA modification in the tumorigenicity of cancer cells and how post-transcriptional modifications influence tumor initiation, maintenance, and progression, (3) elucidating the regulatory mechanisms of exosomes in driving cancer metastasis, and (4) exploring the practical therapeutic approaches for inhibiting obesity or diabetes-related cancer and their molecular mechanisms.
Dr. Hao has the expertise, leadership, training, and motivation necessary to complete his research projects.